NextCure, Inc.NXTCNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank75
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P75
Within normal range
vs 2Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20253.57%
202411.66%
202310.90%
2022-7.27%
2021-71.66%
2020-9.99%
2019-61.59%
2018-49.18%
20170.00%